https://scholars.lib.ntu.edu.tw/handle/123456789/626631
標題: | Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia | 作者: | Mitsudomi, Tetsuya Tan, Daniel CHIH-HSIN YANG Ahn, Myung-Ju Batra, Ullas Cho, Byoung-Chul Cornelio, Gerardo Lim, Tony Mok, Tony Prabhash, Kumar Reungwetwattana, Thanyanan Ren, Sheng-Xiang Singh, Navneet Toyooka, Shinichi Wu, Yi-Long PAN-CHYR YANG Yatabe, Yasushi |
關鍵字: | Adenocarcinoma; Biomarkers; Liquid biopsy; Non–small cell lung cancer; Squamous carcinoma; ctDNA | 公開日期: | 12-四月-2023 | 卷: | 18 | 期: | 4 | 起(迄)頁: | 436 | 來源出版物: | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 摘要: | Most published guidelines for genomic biomarker testing in NSCLC reflect the disease epidemiology and treatments readily available in Europe and North America. Nevertheless, 60% of annual global NSCLC cases occur in Asia, where patient characteristics, tumor molecular profiles, and treatments vary greatly from the Western world. For example, mutations in the EGFR occur at a higher prevalence in Asia than in other world regions. Although medical associations such as the International Association for the Study of Lung Cancer, European Society for Medical Oncology, and American Society of Clinical Oncology have described principles for tumor genomic biomarker testing in NSCLC, there is a need for recommendations specific for Asia. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/626631 | ISSN: | 15560864 | DOI: | 10.1016/j.jtho.2022.10.021 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。